Preoperative Endocrine Therapy for Clinical Stage A₂, B, and C Prostate Cancer: An Interim Report on Short‐Term Effects

Abstract

Preoperative endocrine therapy reduced local extension of prostate cancer, and the effects depended on histologic differentiation and PSA level. Long-term follow-up data are needed to determine the effects on the patient prognosis.